Related Experiment Video
Updated: Mar 14, 2026
10:16
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
4.2K
Zika Virus Replicons for Drug Discovery
Xuping Xie1, Jing Zou1, Chao Shan1
1Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Ebiomedicine
|September 24, 2016
Summary
Researchers developed two Zika virus (ZIKV) replicon systems for studying viral replication and developing countermeasures. These systems enable efficient antiviral screening without using infectious Zika virus, accelerating research.
Area of Science:
- Virology
- Molecular Biology
- Infectious Diseases
Background:
- The Zika virus (ZIKV) epidemic highlights the need for robust experimental systems.
- Studying ZIKV replication, pathogenesis, and developing countermeasures are critical.
- Existing methods may be limited in efficiency or safety.
Purpose of the Study:
- To establish novel experimental systems for ZIKV research.
- To develop tools for studying viral translation, RNA synthesis, and inhibitor screening.
- To facilitate both basic and translational research on ZIKV.
Main Methods:
- Development of a transient luciferase replicon system for ZIKV.
- Creation of a stable ZIKV replicon-carrying cell line.
- Utilizing a 96-well format for high-throughput antiviral screening.
Main Results:
- The transient replicon differentiated viral translation and RNA synthesis.
- A specific NS5 polymerase mutation's effect on RNA synthesis was evaluated.
- The replicon cell line enabled antiviral screening without infectious virus.
Conclusions:
- The developed ZIKV replicon systems are valuable tools for research.
- These systems accelerate the study of viral replication and pathogenesis.
- They provide a safer and more efficient platform for antiviral countermeasure development.
